PREVENTIVE MEASURES OF OVARIAN HYPERSTIMULATION SYNDROME

PROGESTIN-PRIMED OVARIAN STIMULATION VERSUS GNRH ANTAGONIST IN LOW OVARIAN RESERVE PATIENTS UNDERGOING ICSI CYCLES

Coasting Versus GnRH Antagonist administration in Patients at High Risk of Ovarian Hyper stimulation Syndrome and its impact on the ICSI Outcome

Using Anti-Müllerian Hormone and Serum Estradiol to Predict Ovarian Hyperstimulation Syndrome in Patients Using Antagonist Protocol During IVF/ICSI Cycles

Aromatase Inhibitors Versus Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome: a Prospective, Randomized, Double-Blind Study

THE EFFECT OF COASTING AS A PREVENTIVE MEASURE FOR OVARIAN HYPERSTIMULATION SYNDROME (OHSS) ON INTRACYTOPLASMIC SPERM INJECTION (ICSI) OUTCOME

EFFECT OF THE CABERGOLINE IN IMPLANTATION WHEN ADMINISTERED TO PREVENT OVARIAN HYPERSTIMULATION SYNDROME

Comparison between Cabergoline and Coasting in Prevention of Ovarian Hyperstimulation Syndrome and their effect on Intracytoplasmic Sperm Injection Outcome

Effect of estradiol pretreatment on antagonist ICSI cycles outcome: A Randomized controlled trial

Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation